Co-stimulation agonists as a new immunotherapy for autoimmune diseases

Publisher： Elsevier

ISSN： 1471-4914

Source： Trends in Molecular Medicine, Vol.9, Iss.11, 2003-11, pp. : 483-489

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 3, 2012-07 ,pp. : 224-235

Bentham Science Publishers

Access to resources Recommend Favorite

T-cell-based immunotherapy of autoimmune diseases

By Ulivieri Cristina Baldari Cosima T

Expert Review of Vaccines, Vol. 12, Iss. 3, 2013-03 ,pp. : 297-310

Informa Healthcare

Access to resources Recommend Favorite

The double life of NK receptors: stimulation or co-stimulation?

By Snyder M.R. Weyand C.M. Goronzy J.J.

Trends in Immunology, Vol. 25, Iss. 1, 2004-01 ,pp. : 25-32

Elsevier

Access to resources Recommend Favorite

ICOS Costimulation: Is It the Key to Selective Immunotherapy?

By Sperling A.I.

Clinical Immunology, Vol. 100, Iss. 3, 2001-09 ,pp. : 261-262

Academic Press

Access to resources Recommend Favorite

Autoimmune Channelopathies: Well-Established and Emerging Immunotherapy-Responsive Diseases of the Peripheral and Central Nervous Systems

By Vincent Angela

Journal of Clinical Immunology, Vol. 30, Iss. 1, 2010-05 ,pp. : 97-102

Springer Publishing Company

Access to resources Recommend Favorite